Jin Medical International Ltd.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 10.5
- Dividend yield
- –
About Jin Medical International
Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842
Jin Medical International Ltd. is a holding company that develops and manufactures medical and technology products through its operating entities in the People's Republic of China. The company produces equipment and components across dedicated production facilities, while also expanding into newer product categories. It supplies these products through an established commercial network composed of independent distributors and dealers, serving commercial clients as well as a major primary customer that accounts for a significant portion of its sales volume.
The company operates primarily within mainland China, with operational subsidiaries and manufacturing infrastructure situated across Jiangsu Province, Changzhou City, and Shanghai. It sources materials from a specialized supplier base to support its domestic production capacity. Jin Medical International Ltd. is incorporated in the Cayman Islands and maintains its principal executive offices in Changzhou City, Jiangsu Province, People's Republic of China.
Summary of the business section of Jin Medical International's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Jin Medical International Ltd.
- Headquarters
- Jiangsu Province, F4
- Address
- No. 33 Lingxiang Road, Wujin District, Changzhou City 213149
- Phone
- (86)51989607972
- Employees
- 40, Sep 30, 2025
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Incorporated in
- E9
- Fiscal year ends
- September 30
- Auditor
- Audit Alliance LLP, Singapore
Stock & identifiers
- Ticker
- ZJYL
- Exchange
- Nasdaq
- IPO date
- Mar 29, 2023
- Shares outstanding
- 157M, Sep 30, 2025
- Filer category
- Non-accelerated filer<br>Emerging growth company
- Stock splits
- 1-for-20 reverse, Aug 4, 2026; 1-for-20 reverse, Mar 16, 2026; 20-for-1, Feb 8, 2024; 20-for-1, Feb 8, 2024
- SEC CIK
- 1837821
- CUSIP
- G5140V120
- ISIN
- USG5140V1203
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Ziqiang Wang | Chief Financial Officer, Director | – |
| Erqi Wang | Chief Executive Officer, Director | 5,306,307 |
| Ning Xue | Director | – |
| Oliver St Clair Franklin Jr | Director | – |
| James Jiayuan Tong | Director | – |
| Yanru Guo | Director | – |
Employees
Headcount reported in annual reports
“has 40 employees as of the date of this report, many of whom own advanced degrees in engineering and related fields.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jan 30, 2026 | Late filing | Notification of late filing |
| Jan 31, 2024 | Late filing | Notification of late filing |
| Mar 29, 2023 | IPO | Initial public offering priced (424B4 prospectus) |
| Mar 23, 2023 | Listing | Registration of securities on an exchange (Form 8-A) |